HomeInflammatix

Inflammatix

New Study Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System

Study demonstrates its ability to identify patients with bacterial versus viral infections using a data-driven approach that measures the immune system response. The molecular classifier used in the study forms the basis of Inflammatix's HostDx rapid tests, which the company is developing to overcome the traditional challenges of diagnosing acute infections and sepsis.